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The Effect of Intensive Antibacterial Therapy on the
Sulcular Environment in Monkeys*
Part I. Changes in the Bacteriology of the Gingival Sulcus
Kenneth S. Kornmanf Raul G. Caffesse.ij: and Carlos E. Nasjleti§
The changes induced in the bacteriology of the gingival sulcus were evaluated as part of a
study considering the keratinizing potential of the sulcular epithelium when bacterial plaque
was essentially eliminated.
Two Rhesus monkeys were scaled and placed on a daily therapeutic regimen which included
a prophylaxis, systemic tetracycline, and topical Chlorhexidine. Over the 40 day experimental
period and 74 days post-therapy, subgingival plaque samples were taken periodically. The
plaque samples were cultured anaerobically and aerobically to determine the predominant
bacterial flora.
The total cultivable bacterial flora decreased from initial levels by greater than 99.9% with
the antibacterial therapy. The flora shifted with therapy from one dominated by anaerobic
organisms, including Bacteroides melaninogenicus (18%) and Fusobacterium species (13.9%), to
a flora dominated by organisms growing aerobically. During treatment B. melaninogenicus
and Fusobacterium species were not detected in any sample. After cessation of all therapy the
anaerobes increased to dominance again, but B. melaninogenicus remained undetectable
through 74 days post-therapy.
Replacement of the keratinized stratified squamous
epithelium is a continual process involving cells in four
discrete stages of development, based on morphological
criteria, arranged in layers parallel to the surface. Cells
appear to divide, differentiate and migrate into a final
surface layer which is generally thought to be a protective
barrier.
Since periodontal disease appears to begin as a bac-
terial plaque-induced inflammation subjacent to the sul-
cular and junctional epithelium,1'2 the lack of a keratin
layer in these areas has been interpreted as an inherent
weakness in the human gingival sulcus. Therefore, many
studies have attempted to define the nature of the sul-
cular epithelium.3"9 The keratinizing potential for this
tissue has been demonstrated recently in surgical studies
which removed the sulcular epithelium from approxi-
mating the tooth.3'4 It seems appropriate at this time to
evaluate the keratinizing potential of sulcular epithelium
which remains in situ but for which the sulcular environ-
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ment is greatly altered.
This report is part of a study evaluating the keratin-
izing potential of sulcular epithelium when bacterial
plaque is essentially eliminated. The changes induced in
the bacteriology of the gingival sulcus will be presented
here.
MATERIALS AND METHODS
Two adult male Rhesus monkeys (macaca mulatta),
each weighing approximately 17 pounds, were selected
for the present study. Both had a full complement of
permanent teeth with moderate accumulations of supra-
gingival and subgingival calculus and with moderate
generalized gingivitis.
Sodium pentobarbital, 30 mg/kg body weight IV, was
used for all surgical procedures. The monkeys were
sedated with ketamine hydrochloride, 200 mg IM, for
the daily prophylaxes.
Three months prior to the study, two marginal plaque
samples were removed from each monkey and bacterial
isolates were tested for antibiotic sensitivity. Clinical
procedures were performed as outlined in Table 1. At
the initiation of the study (Day = 0) two plaque samples
were taken from each monkey and gingival biopsies were
taken at the sample sites. This was followed by scaling
and polishing to remove all subgingival calculus and
plaque.




ing and included the following procedures once daily for
40 days:
1. Tetracycline hydrochloride (Achromycin®) 75 mg
IV.
2. Rubber cup prophylaxis with prophylaxis paste
(Nupro®). Not performed on weekends.
3. Chlorhexidine gluconate 0.2% in a nonionic gel
applied to the sulcus area by means of syringe and
irrigation needle. The Chlorhexidine was not
washed off after application. Not performed on
weekends.
Additional plaque samples and biopsies were taken
from the buccal aspect ofdifferent teeth in both monkeys
at the times indicated in Table 1.
Bacteriology
Plaque samples were removed with a sterile Columbia
13-14 curette.|| The curette was inserted to the base of
the sulcus. The tooth surface was engaged with the blade
and the curette was moved to the orifice of the sulcus
with a single sweeping motion. The removed plaque was
placed in a 1 dram glass vial containing 1.5 ml of reduced
transport fluid (RTF).10 The prereduced RTF was added
to the vials within an anaerobic glove box,11 and the vials
were sealed and the caps taped prior to removal for
sampling. This was intended to maintain the RTF in a
reduced state until the sample was taken.
The plaque samples were transported to the Oral
Bacteriology Laboratory and placed in the anaerobic
chamber within 1 hour of sampling. All of the following
manipulations were performed within the anaerobic
chamber. Samples were dispersed for 20 seconds by
means of a Kontes Sonifier Model K-881440 set for
maximum output.
Sterile disposable tuberculin syringes were used to
remove 0.5 ml of the dispersed sample and to make serial
1/20, 1/100, and 1/1000 dilutions in RTF. The dilutions
were plated on selective and nonselective media by
means of an automatic diluting and plating device.^
Media
Dilutions were plated on the following selective and
nonselective media:
ETSA: Enriched trypticase soy agar. This is a nonse-
lective blood agar enriched with menadione (1 µg/ml)
and hemin (2 ^g/ml).
GMC: Gelatin-metronidazole (10 µg/ml) Cadmium
sulfate (20 µg/ml) agar. This selective medium allows
isolation and presumptive identification of Actinomyces
viscosus and Actinomyces naeslundii.12
ETSA-K: ETSA with 50 µg/ml Kanamycin sulfate
(Kantrex') for selection of gram-negative organisms.
MM10 with 5% sucrose: The M10 rumen fluid for-
mulation of Caldwell and Bryant (1966) modified to
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* Day 0 samples taken immediately prior to initiation of scaling and
antibacterial therapy.
include known nutrient requirements of the oral flora
and to allow presumptive identification of Streptococcus
sanguis and Streptococcus mutans.10
All media were prereduced in the chamber for at least
24 hours immediately prior to use. Dilutions were plated
as follows:
1/20: ETSA (2), ETSA-K, GMC, MM10
1/100: ETSA (2), ETSA-K, GMC, MM 10
1/1000: ETSA (2)
One ETSA plate from each dilution was incubated at
37 °C in an aerobic incubator. All other plates were
incubated in the anaerobic chamber,* and maintained as
described by Aranki et al.11 with the oxygen level held at
less than 10 parts per million as determined biweekly by
means of a trace oxygen analyzer.f
Anaerobic plates were incubated for 7 days. For each
sample, dilutions which gave plates with well dispersed
colonies were selected.
Sectors including more than 20 colonies were selected
and colonies in two such sectors were quantitated by
means of a binocular dissection microscope. The total
number of colonies and the number of selected colony
types were determined for each sector. Differential
counts and biochemical characterizations of isolates were
keyed to those organisms currently thought to undergo





Bacteroides melaninogenicus (three subspecies)
Bacteroides (Capnocytophaga) ochraceus
II Star Manufacturing Company, Philadelphia,  A.
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Surface translocating bacteria (STB)









8. pH in glucose broth
9. pH in glucose-1-phosphate broth
10. pH in mannitol broth
11. Acid end products by gas liquid chromatogra-
phy





Prior to treatment moderate accumulations of supra-
gingival and subgingival plaque were evident in all sites.
This pretreatment plaque bacterial flora of the monkey
was found to be highly sensitive to tetracycline, as eval-
uated by the modified disc diffusion method.13
The initial plaque samples averaged more than 108
cultivable organisms per sample. These samples were
dominated by bacteria which preferred anaerobic growth
conditions, as evidenced by the anaerobe/aerobe ratio of
3.20. Differential counts of the cultivable flora revealed
Bacteroides melaninogenicus (18.2%), Fusobacterium spe-
cies (13.9%) and Streptococcus sanguis (22.4%) as major
components (Table 2).
The B. melaninogenicus isolates lowered the pH below
6.0 in glucose broth, produced indole from tryptophane,
and failed to hydrolyze esculin. They were therefore
classified as subspecies intermedius. A few isolates at 0
time were compatible with B. melaninogenicus subspecies
asaccharolyticus (Bacteroides asaccharolyticus).
Antibacterial therapy included daily tetracycline IV,
and prophylaxis and Chlorhexidine applications daily on
weekdays. This therapy produced an absolute decrease
in the cultivable flora from 108 organisms/sample prior
to treatment to 104 organisms/sample after 40 days of
treatment. These data indicate that more than 99.9% of
the plaque flora was eliminated.
The anaerobe/aerobe ratio decreased markedly after
initial preparation of the animals but increased again to
approximately 1.90 by 7 days. By Day 19 the anaerobe/
aerobe ratio had started to decline and remained below
1.00 from Day 27 to the termination of the antibacterial
therapy 13 days later (Table 2, Fig. 1).
Actinomyces viscosus, Actinomyces naeslundii, Bacte-
roides melaninogenicus, and Bacteroides (Capnocyto-
phaga) ochraceus could not be detected in samples 3 days
after therapy began and remained undetectable through-
out the treatment. Absolute numbers of Streptococcus
sanguis declined during treatment, but this organism
became dominant in samples taken early in the treat-
ment. In later samples, S. sanguis shared prominence
with another streptococcus which was adherent and re-
fractile on 5% sucrose agar, did not lower the pH in
mannitol broth, and did not hydrolyze esculin. This
organism is compatible with S. sanguis II as described
by Facklam.14
Bacterial counts, after cessation of all treatment, in-
creased significantly from 104 cultivable organisms/ml
sample to 9 X 106 organisms/ml sample 36 days after
ending treatment. The anaerobe/aerobe ratio increased
to approximately 2.0 within the first week after stopping
Table 2.





































































































* Time 0 samples taken prior to initiation of scaling and antibacterial therapy,
t Number of plaque samples cultured.
£ Total colony forming units (CFU) on a nonselective medium incubated anaerobically, ± standard deviation.
§ Ratio of total CFU of duplicate nonselective plates, one incubated anaerobically and the other aerobically.
II Includes three subspecies.
 Percent of total CFU, ± standard deviation.
** Not detectable; less than 1035 organisms in the total plaque sample.
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treatment. By 36 days post-treatment, the ratio had
exceeded pretreatment levels and continued to increase
through 74 days post-treatment (Table 3, Fig. 1).
Actinomyces viscosus remained undetectable in post-
treatment samples, but Actinomyces naeslundii increased
to approximately 18% of the cultivable flora. Only two
plaque samples were cultured at the last period, and the
mean is not truly representative of the levels (34.0% and
2.7%) of A. naeslundii in the individual samples. B.
melaninogenicus was undetectable in all post-treatment
samples. Fusobacterium species increased from undetect-
able to approximately 40% of the flora and B. (Capno-
cytophagd) ochraceus increased to approximately pre-
treatment levels (Table 3).
DISCUSSION
The plaque bacterial flora of the Rhesus monkey
appears qualitatively similar to that described for man.
The flora associated with chronic gingivitis in man gen-
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Figure 1. Anaerobe/aerobe ratio during and after antibacterial therapy. X Ratio of total number of specimens cultured anaerobically to total number of
organisms cultured aerobically. * Initial histologie evidence of the keratinization of sulcular epithelium.
Table 3.
Plaque Bacterial Flora Changes After Cessation ofAll Antibacterial Therapy





















































* Number of days after concluding all antibacterial therapy,
f Number of plaque samples cultured.
% Total colony forming units (CFU) on a nonselective medium incubated anaerobically, ± standard deviation.
§ Ratio of total CFU of duplicate nonselective plates, one incubated anaerobically and the other aerobically.
II Includes three subspecies.
H Not detectable; less than 1035 organisms in the total plaque sample, ± standard deviation.
** Percent of total CFU.
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and lower levels of B. melaninogenicus and Fusobacte-
rium species than were observed in the pretreatment
samples reported above.15 A recent study of supragingi-
val plaque in monkeys also noted a low level of Actino-
myces species (<1.0%).16 In these quantitative respects,
the monkey plaque flora has some resemblance to the
flora of the beagle dog.17
The shift in the anaerobe/aerobe ratio, as treatment
progressed, suggests that selective changes occurred in
the flora rather than merely a nonspecific suppression of
all organisms. The anaerobe/aerobe ratio appeared to
decrease with initial treatment; then successively increase
and decrease after Day 13; and finally stabilize, with
aerobically grown organisms outnumbering anaerobi-
cally grown organisms. This pattern may be attributed
to an immediate regrowth of anaerobes which use as
nutrients products from tissue breakdown which should
be available after scaling. If the flora then was main-
tained relatively stable by the antibacterial treatment
and if the gingiva was allowed to achieve a healthy state,
nutrients from the tissue may have been unavailable.
Thus, these rather fastidious organisms may have been
depleted due to a lack of tissue-provided nutrients.
B. melaninogenicus failed to return to detectable levels
up to 70 days after cessation of all antiplaque treatment.
After treatment, Fusobacterium species increased to a
proportional level which, in the pretreatment samples,
would have included both that group of organisms and
B. melaninogenicus. An apparent competitive relation-
ship between Fusobacterium and B. melaninogenicus is
not an uncommon finding in clinical samples.18
Recent evidence19"22 suggests that specific bacteria are
associated with periodontal disease. If a causal relation-
ship can be determined, it then becomes practical to
direct therapy towards elimination or suppression of
specific plaque organisms. Although intensive local ther-
apy or chemotherapy may induce long-lasting changes
in the bacterial flora, little evidence23 exists to support
this hypothesis. The present study demonstrates that
intensive antibacterial therapy, both local and systemic,
produces a major shift in the subgingival flora, and that
qualitative and quantitative shift appears to persist at
least 74 days after cessation of all treatment.
CONCLUSIONS
1. Daily prophylaxes, systemic tetracycline, and topi-
cal Chlorhexidine applications produced a marked sup-
pression of the subgingival bacterial flora.
2. Qualitative alterations of the flora appeared pro-
longed even after cessation of all antibacterial treatment.
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